EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vaccine Candidates against Arenavirus Infections

Takeshi Saito iD, Rachel A Reyna iD, Satoshi Taniguchi iD, Kirsten Littlefield iD, Slobodan Paessler, Junki Maruyama iD

Vaccines · 13.03.2023 · 11 (3) · 635

DOI: 10.3390/vaccines11030635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 13.03.2023. Verfasst von Takeshi Saito und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, Uehara Memorial Foundation and McLaughlin Fellowship Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The viral family Arenaviridae contains several members that cause severe, and often lethal, diseases in humans. Several highly pathogenic arenaviruses are classified as Risk Group 4 agents and must be handled in the highest biological containment facility, biosafety level-4 (BSL-4). Vaccines and treatments are very limited for these pathogens. The development of vaccines is crucial for the establishment of countermeasures against highly pathogenic arenavirus infections. While several vaccine candidates have been investigated, there are currently no approved vaccines for arenavirus infection except for Candid#1, a live-attenuated Junin virus vaccine only licensed in Argentina. Current platforms under investigation for use include live-attenuated vaccines, recombinant virus-based vaccines, and recombinant proteins. We summarize here the recent updates of vaccine candidates against arenavirus infections.

Schlagwörter

Stichwörter der Autor:innen

Junin virusLassa virusarenavirusvaccinevirus attenuation

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID-Profile: Takeshi Saito, Rachel A Reyna, Satoshi Taniguchi, Kirsten Littlefield, Junki Maruyama

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • Uehara Memorial Foundation and McLaughlin Fellowship Fund
  • National Institutes of Health

Zitieren

APA

Saito, T., Reyna, R. A., Taniguchi, S., Littlefield, K., Paessler, S., & Maruyama, J. (2023). Vaccine Candidates against Arenavirus Infections. Vaccines, 11(3), 635. https://doi.org/10.3390/vaccines11030635

Vancouver

Saito T, Reyna RA, Taniguchi S, Littlefield K, Paessler S, Maruyama J. Vaccine Candidates against Arenavirus Infections. Vaccines. 2023;11(3):635. doi:10.3390/vaccines11030635

BibTeX
@article{Saito2023,
  author = {Saito, Takeshi and Reyna, Rachel A and Taniguchi, Satoshi and Littlefield, Kirsten and Paessler, Slobodan and Maruyama, Junki},
  title = {Vaccine Candidates against Arenavirus Infections},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {635},
  doi = {10.3390/vaccines11030635}
}
Kostenlos starten →